Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study

GSK3532795 (formerly BMS955176) is a second-generation maturation inhibitor (MI) that progressed through a Phase 2b study for treatment of HIV-1 infection. Resistance development to GSK3532795 was evaluated through in vitro methods and was correlated with information obtained in a Phase 2a proof-of-...

Descripción completa

Detalles Bibliográficos
Autores principales: Dicker, Ira, Zhang, Sharon, Ray, Neelanjana, Beno, Brett R., Regueiro-Ren, Alicia, Joshi, Samit, Cockett, Mark, Krystal, Mark, Lataillade, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797179/
https://www.ncbi.nlm.nih.gov/pubmed/31622432
http://dx.doi.org/10.1371/journal.pone.0224076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797179/
https://www.ncbi.nlm.nih.gov/pubmed/31622432
http://dx.doi.org/10.1371/journal.pone.0224076

Ejemplares similares